Related Experiment Video
Updated: May 15, 2025

08:45
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
6.1K
Identification of small molecule activators targeting TYK2 pseudokinase domain
Hirokazu Matsumoto1, Tien-Cheng Wang1, Haruka Taniguchi1
1Carna Biosciences, Inc., Kobe 650-0047, Japan.
Bioorganic & Medicinal Chemistry Letters
|April 10, 2025
Summary
Researchers discovered novel aminopyridine analogs that activate Tyrosine Kinase 2 (TYK2), an important enzyme in immune responses. Compound 16b showed a dose-dependent increase in TYK2 enzymatic activity, suggesting potential therapeutic applications.
Area of Science:
- Immunology
- Biochemistry
- Drug Discovery
Background:
- Tyrosine Kinase 2 (TYK2) is essential for adaptive and innate immunity.
- The TYK2 JH2 pseudokinase domain regulates the catalytic JH1 domain, maintaining an inactive state.
- Understanding TYK2 regulation is crucial for developing immunomodulatory therapies.
Purpose of the Study:
- To discover novel activators of Tyrosine Kinase 2 (TYK2).
- To explore the potential of aminopyridine analogs as TYK2 modulators.
- To investigate the structure-activity relationship of modified JH2 binders.
Main Methods:
- Structural modification of a known TYK2 JH2 domain binder.
- Synthesis of aminopyridine analogs.
- Enzymatic assays to measure TYK2 activity.
Main Results:
- Discovery of novel aminopyridine analogs as TYK2 activators.
- Compound 16b demonstrated significant dose-dependent activation of TYK2 enzymatic activity.
- Identification of specific structural modifications leading to TYK2 activation.
Conclusions:
- Aminopyridine analogs represent a new class of TYK2 activators.
- Compound 16b shows promise as a tool for studying TYK2 function or as a therapeutic lead.
- Further research is warranted to explore the therapeutic potential of these novel activators.
Related Concept Videos
Receptor Tyrosine Kinases
11.9K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
11.9K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
The JAK-STAT Signaling Pathway
8.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.5K
Amplifying Signals via Enzymatic Cascade
8.2K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.2K
Enzyme-linked Receptors
76.5K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
76.5K

